Thrivent International Equity Fund underperformed its benchmark for the quarter in the face of challenging factor performance ...
Levi & Korsinsky, LLP notifies investors in Cytokinetics, Incorporated ("Cytokinetics" or the "Company") of a class action securities ...
Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback